RNAZ icon

TransCode Therapeutics
RNAZ

Overview Fund Trends Analyst Outlook Journalist POV

1 hedge funds and large institutions have $2.67M invested in TransCode Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.62M

Top Sellers

1
-$934K
2
-$792K
3
-$576K
4
RAM
Redmond Asset Management
Virginia
-$262K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$205K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.62M
2
$447K
3
$252K
4
$115K
5
$96K
6
$26K
7
$25K
8
$25K
9
$20K
10
$19K
11
$8K
12
$8K
13
–
14
–